Abstract:AbstractPurposeTo explore the relevance of cytogenetic or molecular genetic abnormalities to clinical variables, including clinical and laboratory characteristics and prognosis in Chinese patients with myelodysplastic syndromes (MDS).MethodsA total of 634 consecutive patients diagnosed with MDS at The First Affiliated Hospital, Zhejiang University School of Medicine from June 2008 to May 2018 were retrospectively included in this study. All patients had evaluable cytogenetic analysis, and 425 patients had MDS‐related mutations sequencing.Results38.6% of patients displayed abnormal karyotypes. The most common cytogenetic abnormality was +8 (31%). Sole +8 was related to female (p = 0.002), hemoglobin >10 g/dL (p = 0.03), and <60 years old (p = 0.046). TP53 mutations were associated with complex karyotype (CK) (p < 0.001). DNMT3A mutations correlated with ‐Y (p = 0.01) whereas NRAS mutations correlated with 20q‐ (p = 0.04). The overall survival (OS) was significantly inferior in patients with +8 compared with those with normal karyotype (NK) (p = 0.003). However, the OS of sole +8 and +8 with one additional karyotypic abnormality was not different from NK (p = 0.16), but +8 with two or more abnormalities had a significantly shorter OS than +8 and +8 with one additional karyotypic abnormality (p = 0.02). In multivariable analysis, ≥60 years old, marrow blasts ≥5% and TP53 mutations were independent predictors for poor OS (p < 0.05), whereas SF3B1 mutations indicated better prognosis. Male IDH1 and IDH2 mutations and marrow blasts ≥5% were independent risk factors for worse leukemia free survival (LFS) (p < 0.05).ConclusionIn this population of Chinese patients, trisomy 8 is the most common karyotypic abnormality. Patients with +8 showed a poorer OS compared with patients with NK. Sole +8 and +8 with one additional karyotypic abnormality had similar OS with NK, whereas +8 with two or more abnormalities had a significantly shorter OS. DNMT3A mutations correlated with ‐Y and NRAS mutations correlated with 20q‐. TP53 mutations were associated with CK and had a poor OS. SF3B1 mutations indicated a favorable OS. IDH1 and IDH2 mutations independently indicated inferior LFS.

Clinical Significance of Karyotype in Evaluating the Prognosis of Acute Myeloid Leukemia (non APL)

Analysis of the Karyotype Abnormalities and Its Prognostic in 298 Patients with Myelodysplastic Syndrome

Karyotypic Analysis and Prognosis for 41 Patients with Chronic Myelomonocytic Leukemia

[Analysis of Age-Specific Cytogenetic Changes among 515 Patients Withacute Myeloid Leukemia].

[Karyotype Analysis of 283 Cases of Myelodysplastic Syndrome].

[Cytogenetic Analysis on 135 Cases of Chronic Myelogenous Leukemias with Non-Simple Philadelphia Chromosome].

Role of chromosome karyotype in the diagnosis and prognosis of acute myeloid leukemia

Clinical Characterization and Prognostic Factors of 144 Adult Acute Monocytic Leukemia

Clinical Significance of Cytogenetic and Molecular Genetic Abnormalities in 634 Chinese Patients with Myelodysplastic Syndromes

Gene mutation patterns and their prognostic impact in a cohort of 1185 patients with acute myeloid leukemia

[Cytogenetic and Molecular Analysis of 1193 Cases with Chronic Myeloid Leukemia].

Cytogenetic Analysis of 1863 Chineses Patients with Chronic Myeloid Leukemia

Analysis of 222 Cases of Acute Myeloid Leukemia Karyotype and Chemotherapeutic Effect

Biological and Clinical Significance of Cytogenetic Study on 100 Acute Lymphoblastic Leukemia and 219 Acute Non-Lymphoblastic Leukemia.

Cytogenetic Analysis on 126 Cases of Acute Leukemia and Its Clinical Significance

Clinical Analysis of Cytogenetic Features in Acute Myeloid Leukemia and Its Relationship with Early Responses after Induction Therapy

Expression of KDR Plus Detection of Flt3-ITD and NPM1 Mutation as a Prognostic Marker in AML Patients with Normal Karyotype.

[Analysis of clinical features of patients with de novo primary acute myeloid leukemia and various chromosomal karyotypes]

[Clinical Significance of Cytogenetic Monitoring in Chronic Myeloid Leukemia].

Karyotype complexity and prognosis in acute myeloid leukemia

[Study on Karyotype of 306 Cases of Myelodysplastic Syndrome].